Luciana Costa Faria

Scopus Publications

Hepatic steatosis and fibrosis are associated with metabolic factors rather than endocrine therapy in breast cancer patients
Mateus Jorge Nardelli, Mísia Joyner de Sousa Dias Monteiro, Guilherme Grossi Lopes Cançado, Tereza Cristina Minto Fontes Cal, Ananda Queiroz Rocha Lima, et al.
Translational Gastroenterology and Hepatology, 2026
Association between body composition, eating behavior, dietary intake, and metabolic dysfunction-associated steatotic liver disease in liver transplant recipients
ACC Cardoso, SC Ferreira, MA Araújo, RPF Mendes, LO do Carmo, et al.
Clinical Nutrition, 2025
Metabolic dysfunction-associated steatotic liver disease and new onset diabetes mellitus after liver transplantation
Marcelo Arouca Araujo, Mateus Jorge Nardelli, Rafael Pereira Freitas Mendes, Amanda Cássia da Cruz Cardoso, Guilherme Grossi Lopes Cançado, et al.
Clinics, 2025
Clinical and Prognostic Factors Associated With Inflammatory Bowel Disease in a Highly Admixed Population With Primary Sclerosing Cholangitis
Mateus Jorge Nardelli, Guilherme Grossi Lopes Cançado, Luísa Leite Barros, Diogo Delgado Dotta, Luciana Costa Faria, et al.
Journal of Clinical Gastroenterology, 2025
Goals: To investigate the prevalence of inflammatory bowel disease (IBD) in a cohort of Brazilian patients with primary sclerosing cholangitis (PSC) and evaluate clinical and prognostic factors associated with concomitant IBD. Background: IBD is reported worldwide in 62% to 81% of patients with PSC, especially in males and north Europeans. Little is known about the association of IBD and PSC in population from multigenetic ethnic origin. Study: Data of PSC patients from the Brazilian Cholestasis Study Group database were retrospectively reviewed to compare demographic, clinical, laboratory, and transplant-free survival between those with and without IBD. Results: After exclusion of 59 (14%) participants with overlap syndrome with autoimmune hepatitis, 359 individuals with PSC were included {56% male, median age 44 [interquartile range (IQR): 33 to 54] y}. IBD was investigated in 298 (83%) participants and diagnosed in 217 (73%), including ulcerative colitis (83%), Crohn’s disease (13%), and indeterminate colitis (4%). Male sex frequency was similar in patients with and without IBD (58% vs. 47%, P=0.073). IBD was more frequently diagnosed in patients without obesity (P=0.035), positive for antinuclear antibody (P=0.006), and positive for anti-smooth muscle antibody (P=0.046). IBD diagnosis occurred before, concomitant, or after PSC diagnosis in 59%, 22%, and 19% of cases, respectively. IBD was more frequently diagnosed before PSC in participants asymptomatic for liver disease (P=0.017), without advanced liver disease (P=0.017), before liver transplantation (LT) (P<0.001), and positive for antinuclear antibody (P=0.021). In a median follow-up of 69 months (IQR 31-124), LT occurred in 27.7% and cohort mortality was 11.4%. IBD was neither associated with the combined outcome of death or LT (P=0.745) nor with transplant-free survival (P=0.902). Conclusions: In Brazilian PSC patients, IBD frequency was similar to that reported in other populations but exhibited a balanced proportion between males and females. IBD diagnosis occurred before PSC in most patients, especially those without advanced liver disease. IBD presence was not associated with worse PSC prognosis.
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium
Paulo Lisboa Bittencourt, Mateus Jorge Nardelli, Luísa Leite Barros, Guilherme Grossi Lopes Cançado, Eduardo Luiz Rachid Cançado, et al.
Clinical Transplantation, 2024
Background and AimPrimary sclerosing cholangitis (PSC) has been shown to recur after liver transplantation (LT). Some studies have identified certain clinical and laboratory variables associated with an increased risk for recurrent PSC (rPSC) in Caucasians. Furthermore, de novo cholangiocarcinoma (CCA) has been reported anecdotally in patients with rPSC. This study aims to assess the prevalence of rPSC, identify its associated risk factors, and investigate the occurrence of de novo CCA in a highly admixed population from Brazil.MethodsAll patients submitted to LT for PSC enrolled in the Brazilian Cholestasis Study Group database were retrospectively reviewed for the occurrence of rPSC and de novo CCA.ResultsNinety‐six (58 males, mean age 32 ± 13 years) patients with PSC underwent LT. After 90 (39–154) months of follow‐up (FU), rPSC was observed in 29 (30%) subjects. There were no significant associations between rPSC and age, gender, concurrent or de novo inflammatory bowel disease, MELD score at the time of LT or allograft rejection. The only factor associated with an increased risk of disease recurrence was time after LT. Although survival was decreased in patients who developed rPSC, this difference was not significant. Only one female patient developed de novo CCA after rPSC, 11 years after LT.ConclusionsRecurrent PSC was observed in one‐third of PSC LT patients in Brazil and was associated with longer time after LT. Despite its frequency, rPSC was not associated with a higher risk of graft loss or a significant reduction in posttransplant survival.
Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis
Guilherme Grossi Lopes Cançado, Patrícia da Silva Fucuta, Nathalia Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, et al.
Clinics and Research in Hepatology and Gastroenterology, 2024
Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis
Ludmila Resende Guedes, Guilherme Grossi Lopes Cançado, Bruno Campos Santos, Luma dos Santos Jacomassi, Mateus Jorge Nardelli, et al.
Annals of Hepatology, 2024
A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score
Guilherme Grossi Lopes Cançado, Nathalia Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Debora Raquel Benedita Terrabuio, et al.
European Journal of Gastroenterology and Hepatology, 2024
Background Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cholangitis (PBC), but a significant proportion of patients do not respond adequately, leading to increased risk of adverse outcomes. This study aims to develop a new and straightforward predictive score to identify PBC patients likely to achieve a complete response to UDCA. Methods A logistic regression analysis was conducted using a derivation cohort of PBC patients to identify pre-treatment variables associated with response to UDCA. This analysis led to the development of the ALP-A score, calculated as: Age at diagnosis divided by (alkaline phosphatase at diagnosis/upper limit of normal). ALP-A score accuracy was evaluated using the area under the ROC curve, validated with a large external cohort from Brazil. Additionally, the correlation between the ALP-A score and the previously validated UDCA response score (URS) was assessed. Results ALP-A score had good predictive power for adequate (AUC 0.794; 95% CI, 0.737–0.852) and deep (0.76; 95% CI, 0.69–0.83) UDCA response at 1 year of treatment. A cutoff score of 17 and 23 points was determined to be the optimal threshold for distinguishing adequate and deep responders, respectively, from non-responders. ALP-A score demonstrated a sensitivity of 73%, specificity of 71%, positive predictive value of 65%, negative predictive value of 78%, and overall accuracy of 72% for biochemical response. The URS displayed similar discriminative ability (AUC 0.798; 95% CI, 0.741–0.855). Conclusion ALP-A score performs comparably to URS but offers the great advantage of simplicity for routine clinical use. It serves as a valuable tool to identify PBC patients less likely to respond to UDCA treatment, facilitating early consideration of alternative therapeutic approaches.
Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study
Gabriela Wünsch Lopes, Scheine Leite Canhada, Rodrigo Citton Padilha dos Reis, Maria de Fátima Haueisen Sander Diniz, Alessandra Carvalho Goulart, et al.
Cadernos De Saude Publica, 2024
We aimed to compare nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) definitions concerning diabetes prediction in a large sample of Brazilian adults. As a secondary objective, we compared associations between NAFLD/MASLD and diabetes across self-declared race/skin color groups. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is a prospective cohort study of Brazilian civil servants (35-74 years) enrolled from 2008 to 2010 and followed up from 2012-2014 and 2017-2019. We ascertained type 2 diabetes mellitus at baseline as well as follow-up visits based on self-reported diagnosis, medication use, and glycemic tests (fasting and 2h post-OGTT glucose and HbA1c). We excluded individuals with heavy alcohol consumption or self-reported cirrhosis/hepatitis. We analyzed 7,073 subjects. NAFLD was defined by ultrasound-based steatosis. Participants with steatosis and at least one cardiometabolic factor were considered as having MASLD. Cox proportional hazards models were performed to evaluate the association between NAFLD/MASLD and the incidence of type 2 diabetes mellitus. At baseline, 33.9% of individuals presented NAFLD and 32.5% presented MASLD. Over 9.4 years of follow-up, the relative increase in the incidence of diabetes was 78% for NAFLD (HR = 1.78; 95%CI: 1.58-2.01) and 88% for MASLD (HR = 1.88; 95%CI: 1.67-2.12). Associations did not differ significantly among race/skin color groups (p for interaction = 0.10 for MASLD and 0.08 for NAFLD). In this large cohort of middle-aged and older Brazilian adults, the relative incidence of diabetes was similar for NAFLD and MASLD definitions, with similar associations in all ethnic groups.
Poor cardiorespiratory fitness may be an indicator of more severe liver inflammation in non-alcoholic fatty liver disease patients
Luciana Carneiro Pena, Cláudia Alves Couto, Bernardo Henrique Mendes Correa, Luisa Fabiana Queiroz Ferrua, Guilherme Grossi Lopes Cançado, et al.
Clinics and Research in Hepatology and Gastroenterology, 2023
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, et al.
Annals of Hepatology, 2023
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis
Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Cristiane Alves Villela-Nogueira, et al.
Digestive Diseases and Sciences, 2023
Occult hepatitis B virus infection in patients with chronic liver disease of different etiology in a Brazilian referral center: comparison of two different hepatitis B virus deoxyribonucleic acid amplification protocols: a cross-sectional study
Alessandra Coutinho de Faria, Bernardo Henrique Mendes Correa, Luciana Costa Faria, Paula Vieira Teixeira Vidigal, Marcelo Antônio Pascoal Xavier, et al.
Sao Paulo Medical Journal, 2023
Liver steatosis as a predictor of incident diabetes in adults: a prospective evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Luciana Costa Faria, Maria de Fátima Haueisen Sander Diniz, Luana Giatti, Maria Inês Schmidt, Alessandra Carvalho Goulart, et al.
Cadernos De Saude Publica, 2023
Dietary pattern in women with polycystic ovary syndrome with and without associated non-alcoholic fatty liver disease: A cross-sectional study
Thais Cristine Moura Guimarães, Daniela Oliveira de Lima Taranto, Claudia Alves Couto, Mateus Jorge Nardelli, Ana Lucia Cândido, et al.
Clinics, 2023
Sarcopenia, body composition and factors associated with variceal gastrointestinal bleeding and splenectomy in hepatosplenic schistosomiasis mansoni
Fernanda A Barbosa, Mateus J Nardelli, Guilherme G L Cançado, Catherine F Silva, Fernanda M F Osório, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2022
Are seizures associated with neuroschistosomiasis mansoni? An exploratory survey in an endemic area of Brazil
Teresa Cristina A Ferrari, Ana Elisa M Oliveira, Maria Júlia S Logato, Carolina G Ganzella, Rodolfo Ferreira Q Melo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2022
Carvedilol as secondary prophylaxis for variceal bleeding in hepatosplenic schistosomiasis
Eliabe Silva de Abreu, Mateus Jorge Nardelli, André Mourão Costa Lima, Jaqueline Brito Cardoso, Fernanda Maria Farage Osório, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2022
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis
Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Debora Raquel Benedita Terrabuio, et al.
Digestive Diseases and Sciences, 2022
Noninvasive predictors of esophageal varices in patients with hepatosplenic schistosomiasis mansoni
Mateus Jorge Nardelli, Zulane da Silva Tavares Veiga, Luciana Costa Faria, Gustavo Henrique Santos Pereira, Catherine Ferreira da Silva, et al.
Acta Tropica, 2022
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Laura Vilar Guedes, Michelle Harriz Braga, Débora Raquel Benedita Terrabuio, et al.
Frontiers in Pharmacology, 2022
Liver stiffness is able to differentiate hepatosplenic Schistosomiasis mansoni from liver cirrhosis and spleen stiffness may be a predictor of variceal bleeding in hepatosplenic schistosomiasis
Catherine F Silva, Mateus J Nardelli, Fernanda A Barbosa, Humberto O Galizzi, Tereza C M F Cal, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2022
Pregnancy Outcomes in Wilson’s Disease Women: Single-Center Case Series
Marcela Chagas Lima Mussi, Mateus Jorge Nardelli, Bruno Campos Santos, Eliabe Silva de Abreu, Fernanda Maria Farage Osório, et al.
Fetal and Pediatric Pathology, 2022
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population
Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Debora Raquel Benedita Terrabuio, et al.
Annals of Hepatology, 2022
Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area
Isabela Dias Lauar, Luciana Costa Faria, Roberta Maia de Castro Romanelli, Wanessa Trindade Clemente
World Journal of Transplantation, 2021
Portal vein thrombosis in patients with hepatosplenic schistosomiasis who underwent oesophagogastric devascularization combined with splenectomy
Guilherme G L Cançado, Mateus J Nardelli, Fernanda A Barbosa, Catherine F Silva, Fernanda M F Osório, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021
Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression
Tereza C. M. Fontes-Cal, Rafael T. Mattos, Nayara I. Medeiros, Bruna F. Pinto, Mayara Belchior-Bezerra, et al.
Frontiers in Immunology, 2021
Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil
Genario Santos, Estela Regina Ramos Figueira, Luiz Augusto Carneiro D’Albuquerque, Paulo Bittencourt Lisboa, Marcio Dias de Almeida, et al.
Annals of Hepatology, 2021
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
Mateus Jorge Nardelli, Paulo Lisboa Bittencourt, Guilherme Grossi Lopes Cançado, Luciana Costa Faria, Cristiane Alves Villela-Nogueira, et al.
Canadian Journal of Gastroenterology and Hepatology, 2021
Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD
Ariane Barros Diniz, Maísa Mota Antunes, Viviane Aparecida de Souza Lacerda, Brenda Naemi Nakagaki, Maria Alice Freitas Lopes, et al.
Jhep Reports, 2020
Circulating levels of High-mobility group box 1 protein and nucleosomes are associated with outcomes after liver transplant
Luciana C. Faria, Antônio Márcio F. Andrade, Cyntia G. M. C. Trant, Agnaldo S. Lima, Pedro A. B. Machado, et al.
Clinical Transplantation, 2020
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
Daniela Oliveira de Lima Taranto, Thais Cristine Moura Guimarães, Claudia A. Couto, Ana Lúcia Cândido, Rosana Correa Silva Azevedo, et al.
Archives of Endocrinology and Metabolism, 2020
Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment
Paulo Henrique Costa Diniz, Serena Dafne do Carmo Silva, Luciana Costa Faria, Paula Vieira Teixeira Vidigal, Teresa Cristina de Abreu Ferrari
Clinics, 2020
Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma
Paulo H. C. Diniz, Serena D. C. Silva, Paula V. T. Vidigal, Marcelo A. P. Xavier, Cristiano X. Lima, et al.
Journal of Oncology, 2020
Wilson's disease presentation resembling autoimmune hepatitis
Bruno Campos Santos, Ludmila Resende Guedes, Luciana Costa Faria, Claudia Alves Couto
BMJ Case Reports, 2019
Update of the brazilian society of hepatology recommendations for diagnosis and management of autoimmune diseases of the liver
Cláudia Alves COUTO, Debora Raquel Benedita TERRABUIO, Eduardo Luiz Rachid CANÇADO, Gilda PORTA, Cynthia LEVY, et al.
Arquivos De Gastroenterologia, 2019
The microbiome and metabolome in nonalcoholic fatty liver disease
Silvia M. Ferolla, Cláudia A. Couto, Maria de Lourdes A. Ferrari, Luciana Costa Faria, Murilo Pereira, et al.
Microbiome and Metabolome in Diagnosis Therapy and Other Strategic Applications, 2019
Viral hepatitis recommendations for solid-organ transplant recipients and donors
Luciana Costa Faria, Débora Raquel Benedita Terrabuio, Hakan Leblebicioglu, Shirish Huprikar
Transplantation, 2018
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America
Wanessa Trindade Clemente, Lígia Camera Pierrotti, Edson Abdala, Michele I. Morris, Luiz S. Azevedo, et al.
Transplantation, 2018
Budd Chiari syndrome associated with AL amyloidosis: a coagulation paradox
Guilherme Grossi Lopes Cançado, Luciana Costa Faria, Fernanda Maria Farage Osório, Paula Vieira Teixeira Vidigal, Cláudia Alves Couto, et al.
Amyloid, 2018
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
A. L. L. Rocha, L. C. Faria, T. C. M. Guimarães, G. V. Moreira, A. L. Cândido, et al.
Journal of Endocrinological Investigation, 2017
Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver
Paulo Lisboa Bittencourt, Eduardo Luiz Rachid Cançado, Cláudia Alves Couto, Cynthia Levy, Gilda Porta, et al.
Arquivos De Gastroenterologia, 2015
Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral center
T.C.A. Ferrari, M.A.P. Xavier, P.V.T. Vidigal, N.S. Amaral, P.A. Diniz, et al.
Brazilian Journal of Medical and Biological Research, 2014
High prevalence of asymptomatic leishmania spp. infection among liver transplant recipients and donors from an endemic area of brazil
W.T. Clemente, A. Rabello, L.C. Faria, V. Peruhype-Magalhães, L.I. Gomes, et al.
American Journal of Transplantation, 2014
Impact of model for end-stage liver disease in the occurrence of infectious events and survival in a cohort of liver transplant recipients
W.T. Clemente, R.M.C. Romanelli, L.C. Faria, S.S.S. Lima, L.A. Jesus, et al.
Transplantation Proceedings, 2013
Kinetics of hepatitis C virus load and hemodialysis: Is there any influence of the reuse of dialysis membrane on HCV viremia?
Ronaldo Soares Martins, Olindo Assis Martins Filho, Neiva Sellan Lopes Gonçales, Dora Méndez del Castillo, Luciana Diniz Silva, et al.
Scandinavian Journal of Infectious Diseases, 2012
Visceral leishmaniasis in liver transplant recipients from an endemic area
Wanessa T. Clemente, Luciana C. Faria, Roberta M. C. Romanelli, Stella S. S. Lima, Juliane Raquel G. Cortes, et al.
Transplantation, 2011
Identification and characterization of immune complexes in the cerebrospinal fluid of patients with spinal cord schistosomiasis
Teresa C.A. Ferrari, Luciana C. Faria, Tatiane S. Vilaça, Cristiane R. Correa, Alfredo M. Góes
Journal of Neuroimmunology, 2011
Consensus guidelines for the management of inflammatory bowel disease
Arquivos De Gastroenterologia, 2010
MRSA outbreak at a transplantation unit
R.M.C. Romanelli, W.T. Clemente, S.S.S. Lima, E.M. Rezende, G.H. Martinho, et al.
Brazilian Journal of Infectious Diseases, 2010
Laryngeal histoplasmosis in an immunocompetent patient from a non-endemic region: Case report
Teresa C. A. Ferrari, João Marcos A. Soares, José Maria P. Salles, Júnia S. Handam, Rosana C. S. Azevedo, et al.
Mycoses, 2009
Ultrasound and CT findings in hepatic and pancreatic parenchyma in acute schistosomiasis
M C F PASSOS, L C SILVA, T C A FERRARI, L C FARIA
British Journal of Radiology, 2009
Tuberculosis in liver transplant recipients: A single brazilian center experience
Wanessa T. Clemente, Luciana C. Faria, Stella S. S. Lima, Eduardo G. Vilela, Agnaldo S. Lima, et al.
Transplantation, 2009
Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: A case report
Luciana C. Faria, Clarissa C. Resende, Cláudia A. Couto, Osvaldo F.M. Couto, Lúcia P.C. Fonseca, et al.
Clinics, 2009
An unusual presentation of mesentric panniculitis
Teresa Cristina A. Ferrari, Carolina M. Couto, Tatiane S. Vilaça, Marcelo A.P. Xavier, Luciana C. Faria
Clinics, 2008
Pneumocystis pneumonia: An opportunistic infection occurring in patients with severe alcoholic hepatitis
Luciana Costa Faria, Philippe Ichai, Faouzi Saliba, Sonia Benhamida, Fadi Antoun, et al.
European Journal of Gastroenterology and Hepatology, 2008
Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation
Luciana C. Faria, Michelle Gigou, Anne M. Roque–Afonso, Mylene Sebagh, Bruno Roche, et al.
Gastroenterology, 2008
Clinical characteristics of Crohn's disease in a reference center for bowel diseases
GED Gastrenterologia Endoscopia Digestiva, 2004
Whipple's disease. Report of five cases with different clinical features
Maria de Lourdes de Abreu FERRARI, Eduardo Garcia VILELA, Luciana Costa FARIA, Claudia Alves COUTO, Célio Jefferson SALGADO, et al.
Revista do Instituto De Medicina Tropical De Sao Paulo, 2001

Luciana Costa Faria

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications